KCNT1-RELATED EPILEPSY

Clinical trials for KCNT1-RELATED EPILEPSY explained in plain language.

Never miss a new study

Get alerted when new KCNT1-RELATED EPILEPSY trials appear

Sign up with your email to follow new studies for KCNT1-RELATED EPILEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New epilepsy drug candidate takes first step in human safety trial

Knowledge-focused Recruiting now

This early-stage study tests a new medicine called ABS-1230 in 74 healthy adults to see if it is safe and how the body processes it. The drug is being developed for a rare form of epilepsy (KCNT1-related epilepsy). Participants receive either the drug or a placebo, and researcher…

Matched conditions: KCNT1-RELATED EPILEPSY

Phase: PHASE1 • Sponsor: Actio Biosciences, Inc. • Aim: Knowledge-focused

Last updated May 03, 2026 23:22 UTC

KCNT1-RELATED EPILEPSY

Get alerted when new KCNT1-RELATED EPILEPSY trials appear

New epilepsy drug candidate takes first step in human safety trial